Is now the time to buy this exciting healthcare stock? The post Exciting clinical news for this ASX healthcare stock earns it a buy recommendation appeared first on The Motley Fool Australia.

Thank you for signing up! Did you know with an ad-lite subscription to Burnley Express, you get 70% fewer ads while viewing ...

A surgeon has explained the rules men need to follow before getting tested for cancer - if they want an accurate result.

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Gregory Gaultier backs Anahat Singh’s fearless mindset, discipline and rapid rise, saying she has the mindset needed to win ...

Ramit Tandon discusses his preparation for the Asian Games, Indian squash's growth, and ambitions for Olympic qualification.

Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a prostate cancer early-detection programme funded by Yorkshire Cancer Research.

Brokers have been looking at these shares this week. Are they bullish? The post Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares appeared first on The Motley Fool Australia.

What does it take to be a two-time Olympic Champion? Well, for Alysa Liu, her figure skating regimen reportedly included a ...

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

AS much as the observance of National Women’s Month this month is an occasion to reflect on and celebrate the women of the ...